ANDA 87284, held by Vitarine. Cyproheptadine Hydrochloride.
As of Nov 16, 2026, ANDA 87284 (Cyproheptadine Hydrochloride), held by Vitarine, was not approved, with 2 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Cyproheptadine Hydrochloride4MG ยท tablet;oral | Cyproheptadine Hydrochloride | Discontinued |
| Aug 5, 1983 | Supplement 6Manufacturing | Approved | None posted |
| Nov 22, 1982 | Supplement 5Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters